Koninklijke Philips N.V. $PHG Shares Sold by UBS Group AG

UBS Group AG decreased its stake in shares of Koninklijke Philips N.V. (NYSE:PHG) by 46.7% during the 4th quarter, Holdings Channel reports. The institutional investor owned 176,980 shares of the technology company’s stock after selling 155,199 shares during the period. UBS Group AG’s holdings in Koninklijke Philips were worth $4,793,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the business. Rhumbline Advisers boosted its position in shares of Koninklijke Philips by 1.3% during the 2nd quarter. Rhumbline Advisers now owns 29,306 shares of the technology company’s stock valued at $703,000 after purchasing an additional 388 shares in the last quarter. Franklin Resources Inc. boosted its position in shares of Koninklijke Philips by 3.9% during the 3rd quarter. Franklin Resources Inc. now owns 11,592 shares of the technology company’s stock valued at $316,000 after purchasing an additional 439 shares in the last quarter. Envestnet Portfolio Solutions Inc. boosted its position in shares of Koninklijke Philips by 4.4% during the 3rd quarter. Envestnet Portfolio Solutions Inc. now owns 11,357 shares of the technology company’s stock valued at $310,000 after purchasing an additional 478 shares in the last quarter. Signaturefd LLC boosted its position in shares of Koninklijke Philips by 2.2% during the 4th quarter. Signaturefd LLC now owns 25,598 shares of the technology company’s stock valued at $693,000 after purchasing an additional 546 shares in the last quarter. Finally, First Affirmative Financial Network boosted its position in shares of Koninklijke Philips by 5.1% during the 3rd quarter. First Affirmative Financial Network now owns 11,418 shares of the technology company’s stock valued at $311,000 after purchasing an additional 550 shares in the last quarter. Institutional investors own 13.67% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on PHG. Zacks Research lowered shares of Koninklijke Philips from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 13th. Wall Street Zen upgraded shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Finally, Weiss Ratings lowered shares of Koninklijke Philips from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Thursday, April 2nd. Four analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold”.

Koninklijke Philips Stock Performance

Shares of PHG opened at $27.14 on Friday. Koninklijke Philips N.V. has a one year low of $21.95 and a one year high of $33.44. The company has a 50-day moving average of $27.36 and a two-hundred day moving average of $28.29. The stock has a market cap of $26.13 billion, a price-to-earnings ratio of 23.25, a PEG ratio of 6.90 and a beta of 0.74. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.32 and a quick ratio of 0.90.

Koninklijke Philips (NYSE:PHG) last announced its earnings results on Wednesday, May 6th. The technology company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.24 by $0.03. Koninklijke Philips had a net margin of 5.49% and a return on equity of 13.51%. The company had revenue of $4.52 billion during the quarter, compared to analysts’ expectations of $4.49 billion. On average, equities research analysts expect that Koninklijke Philips N.V. will post 1.87 earnings per share for the current year.

About Koninklijke Philips

Koninklijke Philips N.V. (NYSE: PHG), commonly known as Philips, is a Dutch multinational company focused on health technology. Founded in Eindhoven in 1891, the company evolved from a diversified electronics manufacturer into a specialist in healthcare products, systems and services. Philips is legally registered in the Netherlands and operates globally, supplying equipment and solutions to hospitals, clinics, healthcare providers and consumers across Europe, the Americas and Asia.

Philips’ principal activities center on medical technologies and personal health.